Sterlite reported stellar profitability for 4QFY2011 beating our expectations. The company reported a robust sales growth of 39.9% yoy to Rs10,000cr in 4QFY2011, above our estimates of Rs9,896cr. Net profit grew 35.1% yoy to Rs1,925cr, above our estimate of Rs1,473cr on account of higher-than-expected profit from on Zinc business. We will review our estimates for FY2012 and FY2013 post conference call today. Meanwhile, we maintain our Buy rating on the stock with a target price of Rs215.
4QFY2011 consolidated financial result highlights-
· Net sales increased 39.9% yoy to Rs10,000cr above our expectation of Rs9,896cr. Net sales growth was primarily driven by increase in zinc and lead sales volumes. Zinc production volumes increased 29.0% yoy to 194,000 tonnes, while lead production volumes declined 10.0% yoy to 18,000 tonnes in 4QFY2011.
· EBITDA increased 22.9% yoy to Rs3,059cr, while EBITDA margin expanded 543bp yoy to 30.6%.
· Other income increased 30.9% yoy to Rs725cr, while tax rate declined 190bps yoy to 17.2% in 4QFY2011. Consequently, net profit increased 35.1% yoy to Rs1,925cr, significantly above our estimate of Rs1,368cr.
Exhibit 1: 4QFY2011- Actual vs. Estimates
(Rs cr) | 4QFY11A | 4QFY11E | Variation (%) |
Net Sales | 10,000 | 9,896 | 1.1 |
EBITDA | 3,059 | 2,489 | 22.9 |
EBITDA margins (%) | 30.6 | 25.2 | 543bp |
PBT | 3,296 | 2,911 | 13.2 |
Adj. net income | 1,925 | 1,473 | 30.7 |
Source: Company, Angel Research
Exhibit 2: 4QFY2011 Performance summary
Y/E March (Rs cr) | 4QFY11 | 4QFY10 | % chg | FY2011 | FY2010 | % chg |
Net Sales | 10,000 | 7,147 | 39.9 | 30,248 | 24,501 | 23.5 |
- Consumption of Raw Material | 4,531 | 3,467 | 30.7 | 14,389 | 12,139 | 18.5 |
(% of Net Sales) | 45.3 | 48.5 | 47.6 | 49.5 | ||
- Power& Fuel | 685 | 493 | 39.0 | 2,380 | 1,953 | 21.8 |
(% of Net Sales) | 6.8 | 6.9 | 7.9 | 8.0 | ||
- Staff Costs | 368 | 235 | 56.2 | 1,132 | 854 | 32.5 |
(% of Net Sales) | 3.7 | 3.3 | 3.7 | 3.5 | ||
- Other expenses | 1,414 | 913 | 55.0 | 4,478 | 3,261 | 37.3 |
(% of Net Sales) | 14.1 | 12.8 | 14.8 | 13.3 | ||
Total Expenditure | 6,998 | 5,108 | 37.0 | 22,379 | 18,207 | 22.9 |
(% of Net Sales) | 70.0 | 71.5 | 74.0 | 74.3 | ||
Operating Income | 55.9 | 80.6 | (30.7) | 180.4 | 181.9 | (0.8) |
EBITDA | 3,059 | 2,120 | 44.3 | 8,049 | 6,475 | 24.3 |
EBITDA margin (%) | 30.6 | 29.7 | 26.6 | 26.4 | ||
Interest | 104 | 2 | 6,287.1 | 301 | 292 | 3.0 |
Depreciation | 352 | 225 | 56.7 | 1,030 | 750 | 37.4 |
Other Income | 725 | 554 | 30.9 | 2,472 | 1,506 | 64.1 |
Exceptional Items | (32) | (57) | (297) | |||
Profit before Tax | 3,296 | 2,448 | 34.6 | 9,134 | 6,642 | 37.5 |
(% of Net Sales) | 33.0 | 34.3 | 30.2 | 27.1 | ||
Tax | 566 | 468 | 21.1 | 1,812 | 1,233 | 46.9 |
(% of PBT) | 17.2 | 19.1 | 19.8 | 18.6 | ||
Profit after Tax | 2,730 | 1,981 | 37.8 | 7,322 | 5,409 | 35.4 |
Net Profit | 1,925 | 1,425 | 35.1 | 5,043 | 3,744 | 34.7 |
Source: Company, Angel Research
Outlook and Valuation
Sterlite reported stellar profitability in 4QFY2011. We continue to believe the company is well placed to capitalise on strong metal demand through its expansion plans in the zinc-lead segment, higher merchant power and silver sales. We will review our estimates for FY2012 and FY2013 post conference call today. Meanwhile, we maintain Buy rating on the stock with a target price of Rs215.
Financial Summary
Y/E March ( Rs cr) | FY2008 | FY2009 | FY2010 | FY2011E | FY2012E | FY2013E |
Net Sales | 24,705 | 21,144 | 24,501 | 30,248 | 35,288 | 41,571 |
% chg | 1.3 | (14.4) | 15.9 | 23.5 | 16.7 | 17.8 |
Net Profit | 4,399 | 3,540 | 3,744 | 5,043 | 5,615 | 7,396 |
% chg | (0.5) | (19.5) | 5.8 | 34.7 | 11.4 | 31.7 |
FDEPS(Rs) | 15.7 | 12.3 | 11.9 | 14.3 | 16.7 | 22.0 |
OPM (%) | 31.8 | 22.2 | 25.7 | 26.0 | 24.8 | 28.8 |
P/E(x) | 11.4 | 14.4 | 15.0 | 12.4 | 10.7 | 8.1 |
P/BV(x) | 2.3 | 2.0 | 1.6 | 1.4 | 1.3 | 1.1 |
RoE(%) | 27.3 | 14.8 | 12.0 | 12.9 | 12.8 | 14.4 |
RoCE(%) | 27.2 | 10.6 | 11.8 | 11.8 | 11.6 | 14.5 |
EV/Sales (x) | 2.1 | 2.5 | 2.7 | 2.2 | 1.9 | 1.4 |
EV/EBITDA (x) | 6.7 | 11.0 | 10.4 | 8.6 | 7.5 | 4.8 |
Source: Company, Angel Research
No comments:
Post a Comment